Patents Assigned to DXM Pharmaceutical, Inc.
  • Patent number: 11234897
    Abstract: Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: February 1, 2022
    Assignee: DXM Pharmaceutical, Inc.
    Inventors: Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
  • Publication number: 20210069127
    Abstract: Liquid formulations or syrup comprise an over-the-counter API ingredient or a dietary supplement ingredient. The ingredients are present in concentrated amounts. Multiple doses of the syrups may be packaged in relatively small bottles, such as bottles with a capacity of 100 ml or less.
    Type: Application
    Filed: June 9, 2020
    Publication date: March 11, 2021
    Applicant: DXM Pharmaceuticals, Inc.
    Inventors: Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
  • Publication number: 20180271746
    Abstract: Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
    Type: Application
    Filed: March 26, 2018
    Publication date: September 27, 2018
    Applicant: DXM Pharmaceutical, Inc.
    Inventors: Mark Lawrence Thuesen, Steve Shane Sanders, Steve J. Bannister
  • Patent number: D836459
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: December 25, 2018
    Assignee: DXM Pharmaceutical, Inc.
    Inventors: Mark Lawrence Thuesen, Steve Shane Sanders, Norvan Biglarians